Ebner, Jessica http://orcid.org/0000-0002-4606-6051
Schmoellerl, Johannes http://orcid.org/0000-0002-8461-8881
Piontek, Martin
Manhart, Gabriele
Troester, Selina http://orcid.org/0000-0001-6268-4442
Carter, Bing Z.
Neubauer, Heidi http://orcid.org/0000-0001-7372-7786
Moriggl, Richard http://orcid.org/0000-0003-0918-9463
Szakács, Gergely
Zuber, Johannes http://orcid.org/0000-0001-8810-6835
Köcher, Thomas
Andreeff, Michael http://orcid.org/0000-0002-1144-1958
Sperr, Wolfgang R.
Valent, Peter http://orcid.org/0000-0003-0456-5095
Grebien, Florian http://orcid.org/0000-0003-4289-2281
Article History
Received: 19 March 2023
Accepted: 25 August 2023
First Online: 19 September 2023
Competing interests
: J.Z. is a founder, shareholder and scientific advisor of Quantro Therapeutics GmbH. J.Z. and the Zuber laboratory receive research support and funding from Boehringer Ingelheim. The remaining authors declare no competing interests.